-
公开(公告)号:CY1118713T1
公开(公告)日:2017-07-12
申请号:CY171100321
申请日:2017-03-14
Applicant: UCB BIOPHARMA SPRL
Inventor: ADAMS RALPH , HANCOCK LAURA , HEYWOOD SAM PHILIP
Abstract: Μιαπρωτεΐνησύντηξηςπολυσθενούςαντισώματοςπουπεριλαμβάνειένατμήμαανοσοσφαιρίνης, παραδείγματοςχάριντα Fab ή Fab', μεμιαπρώτηειδικότηταγιαένααντιγόνοενδιαφέροντος, καιπουεπιπλέονπεριλαμβάνειαντισώματααπλώνπεριοχών (dAb) μεειδικότηταγιαέναδεύτεροαντιγόνοενδιαφέροντος, όπουταδυοαντισώματααπλώνπεριοχώνείναισυνδεδεμέναμεταξύτουςμέσωενόςδισουλφιδικούδεσμού. Παρέχονταιεπίσηςσυγκεκριμένεςπρωτεΐνεςσύντηξηςαντισώματοςδιπλήςειδικότηταςπουπεριέχουνένατμήμα Fab ή Fab' καιέναή περισσότερααντισώματααπλώνπεριοχών, ταοποίαείναισταθεροποιημέναμέσωενόςδισουλφιδικούδεσμού.
-
公开(公告)号:PL2334705T3
公开(公告)日:2017-06-30
申请号:PL09736624
申请日:2009-09-25
Applicant: UCB BIOPHARMA SPRL
Inventor: ADAMS RALPH , HANCOCK LAURA , HEYWOOD SAM PHILIP
-
公开(公告)号:HRP20170374T1
公开(公告)日:2017-05-05
申请号:HRP20170374
申请日:2017-03-06
Applicant: UCB BIOPHARMA SPRL
Inventor: ADAMS RALPH , HANCOCK LAURA , HEYWOOD SAM PHILIP
-
公开(公告)号:CA2983770A1
公开(公告)日:2016-11-17
申请号:CA2983770
申请日:2016-05-09
Applicant: UCB BIOPHARMA SPRL
Inventor: BHATTA PALLAVI , DAVE EMMA , HEYWOOD SAM PHILIP , HUMPHREYS DAVID PAUL , SMITH BRYAN JOHN
Abstract: The disclosure relates to antibody fusion proteins specific to FcRn, formulations comprising the same, use of each in therapy, processes for expressing and optionally formulating said antibody, DNA encoding the antibodies and hosts comprising said DNA.
-
公开(公告)号:PL1644412T3
公开(公告)日:2016-02-29
申请号:PL04743158
申请日:2004-07-01
Applicant: UCB BIOPHARMA SPRL
Inventor: HUMPHREYS DAVID PAUL , HEYWOOD SAM PHILIP
-
公开(公告)号:CA2951609A1
公开(公告)日:2015-12-30
申请号:CA2951609
申请日:2015-06-25
Applicant: UCB BIOPHARMA SPRL
Inventor: BHATTA PALLAVI , DAVE EMMA , HEYWOOD SAM PHILIP , HUMPHREYS DAVID PAUL
Abstract: The present disclosure relates to a multi-specific antibody molecule comprising or consisting of: a) a polypeptide chain of formula (I): VH-CH1-X-V1; and b) a polypeptide chain of formula (II): VL-CL-Y-V2 and pharmaceutical formulations comprising, for example for use in treatment. The disclosure also provides polynucleotide sequences encoding said multispecific antibody molecules, vectors comprising the polynucleotides and host cells comprising said vectors and/or polynucleotide sequences. There is a provided a method of expressing a multispecific antibody molecule of the present disclosure from a host cell.
-
公开(公告)号:PT1644412E
公开(公告)日:2015-12-23
申请号:PT04743158
申请日:2004-07-01
Applicant: UCB BIOPHARMA SPRL
Inventor: HUMPHREYS DAVID PAUL , HEYWOOD SAM PHILIP
IPC: C07K16/00
-
公开(公告)号:ES2551439T3
公开(公告)日:2015-11-19
申请号:ES04743158
申请日:2004-07-01
Applicant: UCB BIOPHARMA SPRL
Inventor: HUMPHREYS DAVID PAUL , HEYWOOD SAM PHILIP
Abstract: Un fragmento Fab de anticuerpo caracterizado por que la región constante de la cadena pesada termina en la cisteína intercatenaria de CH1.
-
公开(公告)号:CA2895608C
公开(公告)日:2021-05-25
申请号:CA2895608
申请日:2013-12-20
Applicant: UCB BIOPHARMA SPRL
Inventor: DAVE EMMA , HEYWOOD SAM PHILIP , HUMPHREYS DAVID PAUL
Abstract: The present disclosure relates to a multi-specific antibody molecule comprising or consisting of three polypeptides: a) a polypeptide chain of formula (I):(Vxx)nVx-Cx-X-V1; and b) a polypeptide chain of formula (II): (Vyy)nVy-Cy c) a polypeptide of formula (III):V2 wherein Vx represents a variable domain, Vxx represents a variable domain, Cx represents a constant region, X represents a linker, V represents a variable domain, Vy represents a variable domain, Vyy represents a variable domain, Cy represents a constant region, V2 represents a variable domain, n independently represents 0 or 1, wherein the polypeptide chain of formula (I) and the polypeptide chain of formula (II) is aligned such that the constant regions Cx and Cy are paired and the variable domains Vx and Vy are paired to form a binding domain and optionally a disulphide bond is present between V and V2, in particular where a disulphide bond is present. The disclosure also extends to pharmaceutical formulation comprising the construct, DNA encoding the constructs and vectors comprising same. The disclosure further extends to a method of expressing the constructs, for example in a host cell and methods for formulating same as a pharmaceutical composition. The disclosure also relates to use of the constructs and formulations in treatment.
-
公开(公告)号:ME03539B
公开(公告)日:2020-07-20
申请号:MEP2019274
申请日:2015-06-25
Applicant: UCB BIOPHARMA SPRL
Inventor: BHATTA PALLAVI , DAVE EMMA , HEYWOOD SAM PHILIP , HUMPHREYS DAVID PAUL
IPC: C07K16/46
-
-
-
-
-
-
-
-
-